System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Marc-Antoine Allard is an expert in Surgery at Hôpital Paul-Brousse (France). Marc-Antoine Allard has authored 215 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 709 (community average: 125). How the SLR is computed.

LeadR Profile

Marc-Antoine Allard Hôpital Paul-Brousse France
709 ScienceLeadR Reputation 709

Unlock

Register Login
Network Map

Surgery

Subspecialties: Hepatology - Oncology - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Centre Hépato-Biliaire

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 215

Citations

Citations: 3 600 1st author: 29 Last author: 20 Unique author: 0

Main journals

HPB (Oxford) 23
Ann Surg 15
Ann Surg Oncol 14
J Hepatol 14
J Clin Oncol 12

Best Journals

J Hepatol 4
J Clin Oncol 3
Ann Intern Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
PMID 42561547 — pilots, cytoreduction surgical procedures, drug therapy, liver, hepatectomy, neoplasm metastasis, prospective studies, chemotherapy		Cancer Treat Rev20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate		Ann Surg20260
Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?
PMID 42496491 — mortality, lymph node excision, neoplasms, liver, general surgery, cholangiocarcinoma, intrahepatic cholangiocarcinoma		World J Surg20260
Tumor Debulking Plus Chemotherapy in Multiorgan Metastatic Colorectal Cancer.
PMID 42455538 — neoplasms, drug therapy, colorectal neoplasms, chemotherapy		JAMA Top journal20260
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
PMID 42406213 — liver, prognosis, cholangiocarcinoma, intrahepatic cholangiocarcinoma		Ann Surg Oncol20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 2 1

By status:

Completed 3
Not yet recruiting 2
Unknown 2

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 2
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398 — liver diseases, research design, liver transplantation, liver, transplants, organ transplantation, transplantation		Phase 2Not yet recruiting2025
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma		N/ANot yet recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS